Skip to main content
Sopharma AD logo

Sopharma AD — Investor Relations & Filings

Ticker · SFA ISIN · BG11SOSOBT18 LEI · 097900BGGW0000048796 BSOBGN Manufacturing
Open in API
Filings indexed 1,488 across all filing types
Latest filing 2021-11-08 Regulatory Filings
Country BG Bulgaria
Listing BSOBGN SFA

About Sopharma AD

https://www.sopharmagroup.com/

Sopharma AD is a pharmaceutical company founded in 1933 that specializes in the production, distribution, and export of a wide range of medical products. The company's portfolio includes prescription (Rx) and over-the-counter (OTC) medicines, encompassing both branded and generic drugs. A key area of focus is its traditional plant-based products. Sopharma develops treatments for various conditions, including liver disease, pain management, and smoking cessation. Operating from EU-GMP certified facilities, the company also provides contract manufacturing services and has an established presence in over 40 international markets.

Recent filings

Filing Released Lang Actions
Publication of Prospectus for public offering of warrants by “Sopharma" AD in English language
Regulatory Filings Classification · 19% confidence
2021-11-08 Polish
Sales revenues for October 2021
Earnings Release Classification · 100% confidence The document is titled 'Current report №118/ 2021' and provides a brief summary of sales performance (revenues from sales) for October 2021 compared to the previous year, covering both domestic and export sales. This format, providing key financial highlights for a specific period (monthly/ten months) without the full detail of a comprehensive report (like 10-K or IR), strongly aligns with an Earnings Release (ER). It is an initial notification of period results. FY 2021
2021-11-05 English
Notification under Art. 89t of LPOS regarding public offering of warrants by “Sopharma" AD
Capital/Financing Update Classification · 98% confidence The document is a 'Current report' announcing the 'initial public offering of warrants' and details regarding the prospectus approved by the Financial Supervision Commission (FSC). This involves the issuance of new securities (warrants) linked to a future capital increase, which directly relates to the company's capital structure and fundraising activities. This fits the definition of 'Capital/Financing Update' (CAP). Although it mentions a prospectus, the core subject is the offering itself, not just the announcement of a report's publication (RPA) or a general regulatory filing (RNS). The length (2927 chars) suggests it is the substantive announcement, not just a brief notice pointing to an attachment.
2021-11-05 English
Individual financial report according to IFRS as at 30 September 2021
Regulatory Filings Classification · 19% confidence
2021-11-02 Polish
Sales revenues for September 2021
Earnings Release Classification · 100% confidence The document is very short (521 characters) and is titled 'Current report №115/ 2021 Dated October 5, 2021' containing key sales performance metrics for September 2021 and the first nine months of 2021. This format—a brief notification of recent operational/financial highlights without the depth of a full report—is characteristic of an Earnings Release (ER) or a general regulatory announcement. Since it provides specific, period-based financial highlights (sales increase/decrease), 'ER' (Earnings Release) is the most appropriate fit, as it represents the initial announcement of period results. If the document were merely announcing that a full report was available, it would be RPA or RNS, but this document contains the actual summarized data. 9M 2021
2021-10-05 English
Notification from Rositsa Doneva under Art. 19 of Regulation (EU) No 596/2014 of 30 September 2021.
Director's Dealing Classification · 100% confidence The document explicitly states it is a "NOTIFICATION OF INSIDERS' TRANSACTIONS under art. 19 of Regulation 596/2014". It details transactions executed by a person closely associated with the Chairman of the Board of Directors (Mr. Ognian Donev). This directly corresponds to the definition of Director's Dealing (insider trades). Filing Code Mapping: Director's Dealing maps to DIRS.
2021-10-04 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.